Development of new mutant alleles and markers for KTI1 and KTI3 via CRISPR/Cas9-mediated mutagenesis to reduce trypsin inhibitor content and activity in soybean seeds

通过 CRISPR/Cas9 介导的诱变开发 KTI1 和 KTI3 的新突变等位基因和标记，以降低大豆种子中的胰蛋白酶抑制剂含量和活性